Journal Article
. 2018 Feb; 45(1):127-137.
doi: 10.1007/s10928-018-9568-y.

How to mathematically optimize drug regimens using optimal control

Helen Moore 1 
Affiliations
  • PMID: 29411198
  •     24 References
  •     5 citations

Abstract

This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is the application to diseases and therapies, particularly the optimization of combination therapies, and I highlight several such examples. I also describe the basic theory of optimal control, and illustrate each of the steps with an example that optimizes the doses in a combination regimen for leukemia. References are provided for more complex cases. The article is aimed at modelers working in drug development, who have not used optimal control previously. My goal is to make this technique more accessible in the biopharma community.

Keywords: Combination therapy; Constrained optimization; Control theory; Disease modeling; Optimal control.

Optimal control analysis in the chemotherapy of IgG multiple myeloma.
G W Swan, T L Vincent.
Bull Math Biol, 1977 Jan 01; 39(3). PMID: 857983
Application of theoretical models to chemotherapy protocol design.
J H Goldie, A J Coldman.
Cancer Treat Rep, 1986 Jan 01; 70(1). PMID: 3510731
A General Network Pharmacodynamic Model-Based Design Pipeline for Customized Cancer Therapy Applied to the VEGFR Pathway.
X-Y Zhang, M R Birtwistle, J M Gallo.
CPT Pharmacometrics Syst Pharmacol, 2014 Jan 17; 3. PMID: 24429593    Free PMC article.
Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer.
Gary H Lyman, Richard L Barron, Jaime L Natoli, Ross M Miller.
Crit Rev Oncol Hematol, 2011 Jun 04; 81(3). PMID: 21636289
Systematic Review.
Modelling chemotherapy resistance in palliation and failed cure.
Helen C Monro, Eamonn A Gaffney.
J Theor Biol, 2009 Jan 13; 257(2). PMID: 19135065
Relevance of chemotherapy dose and schedule to outcomes in ovarian cancer.
Franco M Muggia.
Semin Oncol, 2005 Feb 24; 31(6 Suppl 15). PMID: 15726535
Review.
DYNAMIC PROGRAMMING AND A NEW FORMALISM IN THE CALCULUS OF VARIATIONS.
R Bellman.
Proc Natl Acad Sci U S A, 1954 Apr 01; 40(4). PMID: 16589462    Free PMC article.
Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy.
R S Day.
Cancer Res, 1986 Aug 01; 46(8). PMID: 3731062
Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Luisa Bonilla, Irit Ben-Aharon, +3 authors, Salomon M Stemmer.
J Natl Cancer Inst, 2010 Nov 26; 102(24). PMID: 21098761    Free PMC article.
Systematic Review.
Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation.
Iftekhar Mahmood.
J Pharm Sci, 2009 Jan 30; 98(10). PMID: 19177515
Estimation and identification of parameters in a lumped cerebrovascular model.
Scott R Pope, Laura M Ellwein, +3 authors, Mette S Olufsen.
Math Biosci Eng, 2009 Mar 19; 6(1). PMID: 19292510
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.
Per Karlsson, Bernard F Cole, +7 authors, International Breast Cancer Study Group.
Int J Radiat Oncol Biol Phys, 2016 Sep 07; 96(2). PMID: 27598802    Free PMC article.
A mathematical model for treatment-resistant mutations of hiv.
Helen Moore, Weiqing Gu.
Math Biosci Eng, 2005 Apr 01; 2(2). PMID: 20369928
A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction.
Helen Moore, Natasha K Li.
J Theor Biol, 2004 Mar 25; 227(4). PMID: 15038986
Optimal control of treatment in a mathematical model of chronic myelogenous leukemia.
Seema Nanda, Helen Moore, Suzanne Lenhart.
Math Biosci, 2007 Jun 30; 210(1). PMID: 17599363
A practical approach to parameter estimation applied to model predicting heart rate regulation.
Mette S Olufsen, Johnny T Ottesen.
J Math Biol, 2012 May 17; 67(1). PMID: 22588357    Free PMC article.
Optimal control of the chemotherapy of HIV.
D Kirschner, S Lenhart, S Serbin.
J Math Biol, 1997 Aug 01; 35(7). PMID: 9269736
Modeling HCV kinetics under therapy using PK and PD information.
Emi Shudo, Ruy M Ribeiro, Alan S Perelson.
Expert Opin Drug Metab Toxicol, 2009 Apr 01; 5(3). PMID: 19331594    Free PMC article.
Review.
The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling.
E A Gaffney.
J Math Biol, 2004 Mar 31; 48(4). PMID: 15052504
Innovation in the pharmaceutical industry: New estimates of R&D costs.
Joseph A DiMasi, Henry G Grabowski, Ronald W Hansen.
J Health Econ, 2016 Mar 02; 47. PMID: 26928437
Highly Cited.
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
M C Peterson, M M Riggs.
CPT Pharmacometrics Syst Pharmacol, 2015 Aug 01; 4(3). PMID: 26225239    Free PMC article.
Mathematical modeling of cyclic treatments of chronic myeloid leukemia.
Natalia L Komarova.
Math Biosci Eng, 2011 Jun 03; 8(2). PMID: 21631131
Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.
A Iliadis, D Barbolosi.
Comput Biomed Res, 2000 Jun 22; 33(3). PMID: 10860586
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.
A Goldhirsch, A S Coates, +2 authors, R D Gelber.
J Clin Oncol, 1998 Apr 29; 16(4). PMID: 9552037
Review.
Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models.
Regina Padmanabhan, Hadeel Shafeeq Kheraldine, +2 authors, Ala-Eddin Al Moustafa.
Cancers (Basel), 2020 Mar 14; 12(3). PMID: 32164163    Free PMC article.
Review.
Genetic Algorithms as a Tool for Dosing Guideline Optimization: Application to Intermittent Infusion Dosing for Vancomycin in Adults.
Pieter J Colin, Douglas J Eleveld, Alison H Thomson.
CPT Pharmacometrics Syst Pharmacol, 2020 May 10; 9(5). PMID: 32383808    Free PMC article.
Control Theory and Cancer Chemotherapy: How They Interact.
Paola Lecca.
Front Bioeng Biotechnol, 2021 Feb 02; 8. PMID: 33520972    Free PMC article.
Review.
Optimum multi-drug regime for compartment model of tumour: cell-cycle-specific dynamics in the presence of resistance.
Bharti Panjwani, Vijander Singh, Asha Rani, Vijay Mohan.
J Pharmacokinet Pharmacodyn, 2021 Mar 23;. PMID: 33751365
How Should Cancer Models Be Constructed?
Robert A Beckman, Irina Kareva, Frederick R Adler.
Cancer Control, 2020 Sep 30; 27(1). PMID: 32991214    Free PMC article.